##gff-version 3
##sequence-region Q9Y484 1 360
Q9Y484	UniProtKB	Chain	1	360	.	.	.	ID=PRO_0000051452;Note=WD repeat domain phosphoinositide-interacting protein 4	
Q9Y484	UniProtKB	Repeat	1	34	.	.	.	Note=WD 1	
Q9Y484	UniProtKB	Repeat	40	84	.	.	.	Note=WD 2	
Q9Y484	UniProtKB	Repeat	92	128	.	.	.	Note=WD 3	
Q9Y484	UniProtKB	Repeat	133	174	.	.	.	Note=WD 4	
Q9Y484	UniProtKB	Repeat	183	222	.	.	.	Note=WD 5	
Q9Y484	UniProtKB	Repeat	227	266	.	.	.	Note=WD 6	
Q9Y484	UniProtKB	Repeat	284	329	.	.	.	Note=WD 7	
Q9Y484	UniProtKB	Alternative sequence	78	78	.	.	.	ID=VSP_016975;Note=In isoform 3. S->SA;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9Y484	UniProtKB	Alternative sequence	145	145	.	.	.	ID=VSP_016976;Note=In isoform 2. K->KAAHPTPHLHTL;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9Y484	UniProtKB	Natural variant	7	360	.	.	.	ID=VAR_078645;Note=In NBIA5. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25356899;Dbxref=PMID:25356899	
Q9Y484	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_080430;Note=In NBIA5%3B unknown pathological significance. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25592411;Dbxref=PMID:25592411	
Q9Y484	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Decreased interaction with ATG2A. Loss of interaction with ATG2A%3B when associated with A-17. N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28561066;Dbxref=PMID:28561066	
Q9Y484	UniProtKB	Mutagenesis	16	16	.	.	.	Note=No effect on interaction with ATG2A. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28561066;Dbxref=PMID:28561066	
Q9Y484	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Decreased interaction with ATG2A. Loss of interaction with ATG2A%3B when associated with A-15. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28561066;Dbxref=PMID:28561066	
Q9Y484	UniProtKB	Mutagenesis	55	55	.	.	.	Note=No effect on interaction with ATG2A. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28561066;Dbxref=PMID:28561066	
Q9Y484	UniProtKB	Mutagenesis	109	109	.	.	.	Note=No effect on interaction with ATG2A. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28561066;Dbxref=PMID:28561066	
Q9Y484	UniProtKB	Mutagenesis	111	111	.	.	.	Note=No effect on interaction with ATG2A. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28561066;Dbxref=PMID:28561066	
Q9Y484	UniProtKB	Mutagenesis	112	112	.	.	.	Note=No effect on interaction with ATG2A. H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28561066;Dbxref=PMID:28561066	
Q9Y484	UniProtKB	Mutagenesis	113	113	.	.	.	Note=Loss of interaction with AMPK. No effect on interaction with ATG2A. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28561066;Dbxref=PMID:28561066	
Q9Y484	UniProtKB	Mutagenesis	114	114	.	.	.	Note=No effect on interaction with ATG2A. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28561066;Dbxref=PMID:28561066	
Q9Y484	UniProtKB	Mutagenesis	232	233	.	.	.	Note=No effect on interaction with ATG2A. RR->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28561066;Dbxref=PMID:28561066	
Q9Y484	UniProtKB	Sequence conflict	217	217	.	.	.	Note=I->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9Y484	UniProtKB	Sequence conflict	300	302	.	.	.	Note=FTV->YTA;Ontology_term=ECO:0000305;evidence=ECO:0000305	
